On June 16, 2026, Medbolide Pharmaceutical JSC co-hosted a session on clinical pharmacology updates at the Outpatient Department of National Hospital of Odonto-Stomatology, Ho Chi Minh City. The session was attended by doctors, pharmacists, and healthcare professionals working at the department.
At the event, a technical representative from Medbolide presented Kadfer—a solution designed to help manage oral and throat symptoms—highlighting the following key features:
- Pain relief and anti-inflammatory properties, making it particularly suitable for oral and throat conditions.
- Proven efficacy through scientific studies, helping to shorten treatment time.
- Ensures a high level of safety, minimizing side effects on the patient’s overall health.
In addition, a representative from Medbolide highlighted the outstanding benefits of Vocfor based on actual scientific evidence. Vocfor is a product line designed for the short-term treatment of acute pain, relief of osteoarthritis-related pain and inflammation, and reduction of pain and inflammation symptoms caused by rheumatoid arthritis. The flexible incorporation of Vocfor into treatment regimens is yielding promising results, helping to improve patients’ quality of life and comfort following dental procedures.
The presentation took place in a lively atmosphere, drawing significant interest, engagement, and high praise from the doctors in the department for the two products, Kadfer and Vocfor.
At the end of the session, the company expressed its sincere gratitude and hope to continue partnering with the hospital in providing effective medical solutions and improving the quality of care for patients. Medbolide Pharmaceutical JSC is proud to be a trusted partner of National Hospital of Odonto-Stomatology, Ho Chi Minh City in providing high-quality, safe medical products, thereby contributing to the mission of promoting oral health for the community.